eco ord rd ded ed ed. Me Me Mean a L L LV V V ejection fraction, indexed L LV V V en e e d-systolic dimen nsi si ion on on, rest RVSP, peakt tr r res s ss R RVS SP, P, M MET ET ETs s ac achi hi h ev ev eved ed a and nd nd H HRR RR w we ere re 5 58± 8±5% 5% %, 1. mm mm mm H Hg, 9.6±3 and nd nd 33 3± ±1 1 14 b bea ea eat ts, re esp spe ec ct ti ively y y. Dur r rin n ng 6 6 6.4 .4 .4±4 ±4 ±4 y y year r rs o of fo o oll low ow w-u u up, th he her re e w w we er re 8 8 87 ev ven en ents ts ts. . On On s s ste te tepw pw wis s se e mu m mult lt l iv ivar r ria iabl bl ble e e Co Co C x x x an an anal al alys ys y is is is, , %a %a %age ge e-g -g -gen en ende de der r r pr pr red d dic ic icte te ed ME ME METs Ts Ts ( ( ( and left atrium (LA), with eventual progression to congestive heart failure (CHF), pulmonary hypertension (PHTN), atrial fibrillation (AF), thromboembolism, stroke and death 3, 4 . Medical management does not convincingly impact disease progression and the majority of patients with severe degenerative MR eventually require surgery 3, 5 .
There is controversy and conflicting evidence about optimal timing of surgery in myxomatous MR patients [6] [7] [8] [9] . In the absence of randomized controlled trials, the guidelines rely mainly on observational outcome studies 10, 11 . Factors such as symptomatic deterioration 3, 12 , severity of disease 13 , increased LV or LA dimensions 14, 15 , and development of AF 16, 17 , PHTN 18 or LV dysfunction 3, 19 have all been associated with worse clinical outcomes. Nevertheless, these studies vary in the definition of outcome 3, 8, 15, 16, 18 , have included limited number of patients 8 , only patients with flail leaflets 14, 15, 18 , patients with various etiologies 12, 19 or severity 3, 18 of MR. Exercise stress echocardiography has not been incorporated in the diagnostic algorithm in the key observational studies on which current management guidelines are based.
Exercise echocardiography is frequently used in patients with significant degenerative MR to aid in symptom evaluation, risk stratification, and decision making (for appropriate timing of surgery) 20 . Exercise testing may provide information additional to the resting echocardiogram on symptomatic status, functional capacity, contractile reserve, dynamic changes in regurgitant severity, and may provoke significant PHTN. Decreased functional capacity during exercise
There is controversy and conflicting evidence about optimal timing of sur ur rge ge ery ry i i in n myxomatous MR patients [6] [7] [8] [9] . In the absence of randomized controlled trials, the guidelines rely ma main in inly ly ly o on n n ob ob obs serv rv va at atio i nal outcome studies 10, 11 . Fa Fa ac ct c o o ors such as symp m m to oma ma mat tic deterioration 3, 12 ,
e eve e eri r ty of dise sea as se e 13 , i inc nc cre re eas as sed ed ed L LV V V or or L LA d dim m mens s sio o ons 14, 14, 14, 15 15 , , a a and nd d de ev evel el lo op opme me ment nt nt o of f AF AF AF 16, 16, 6 17 , , P PHT HT HTN testing 21 , exercise-induced PHTN 22 and MR severity 23 have been associated with worse outcomes. However, available studies involving exercise in MR are relatively small with short follow-up and included patients with varying degrees of MR and heterogeneous endpoints. We therefore sought to assess the predictors of long-term outcomes in patients with moderate-severe (III+) or severe (IV+) myxomatous MR undergoing treadmill echocardiography.
Methods

Study design
This is an observational study of 884 consecutive patients with III+ myxomatous MR who underwent treadmill echocardiography at our institution between January 2000 and December
2011
. We excluded patients with functional MR (including ischemic etiology), prior valvular surgery, hypertrophic cardiomyopathy, rheumatic disease or >mild mitral stenosis. After institutional review board approval, baseline clinical and medication history was manually extracted from electronic health records at a time closest to exercise echocardiography (within 1 month). Presence of paroxysmal ( 30 seconds) or permanent AF or atrial flutter was recorded 24 .
Follow-up clinical data was collected. In the sub-group that underwent surgery, AF occurring within 30-days post-operatively was not included.
Resting and exercise echocardiography
All patients underwent comprehensive echocardiograms using commercial instruments (Philips Medical Systems, N.A., Bothell, Wash and Siemens Medical Solution USA Inc, Malvern, Pa).
LV ejection fraction, indexed LV dimensions and left atrial area were measured according to guidelines 25 . At the point of inclusion in this study, all echo images were re-reviewed to document MR severity. Doppler VCW was re-measured and only patients with VCW 0.5 cm underwent treadmill echocardiography at our institution between January 2000 a an nd nd D Dec ec ecem em embe be ber r 2011. We excluded patients with functional MR (including ischemic etiology), prior valvular f f u urg rg rger er ry y, y, h h hyp yp ype e ertr rop op oph hic cardiomyopathy, rheumati ti ic c c d d disease or >mi ild ld ld m mit it tra ra ral l stenosis. After n nst t tit itutional re evi vi iew ew w b b bo o oard rd rd a a app pp ppr r rov oval al a , , , ba ba ase e eline e e c c clini ica a al an an nd d d m m medi di d ca ca ati ion on h h his i t to tory ry y w w was as m m man an a u u uall ll lly y ex xtr tr trac ac cte te t d d fr fr from om o e el lec ct ctro ro oni nic c he heal al a th th h re re reco c cord rd ds at at at a a a tim im ime e cl l los oses est t t to to to e ex x xer er e ci ci c se se se e ec c cho oc ocar ar rdi di iog og ogra ra rap ph phy y y (w w wit ith h hin n n 1 1 month). Pres sen en ence ce c o o of f f pa pa paro ro r xy xy ysm sm smal al al ( ( ( 30 30 3 s s sec ec econ on onds ds ds) ) ) or or or p p per er e ma ma mane ne nent nt nt A A AF F F or r r a a atr tr tria ia ial l l fl fl flut utte te ter r r wa wa was s s re r corded r r r 24 24 24 .
were included 26 . Because of severity of MR, diastolic function was not reported. Presence of flail mitral leaflet was recorded. Right ventricular systolic function was measured qualitatively as normal, mild, moderate or severe). Right ventricular systolic pressure (RVSP) was measured at rest, according to guidelines 26 .
Subsequently, in conjunction with echocardiography, patients underwent a treadmill test using Bruce protocol under close observation. Patients were instructed to hold their medications the day of the test. The test was terminated due to symptoms and not at achievement of target heart rate. Blood pressure, heart rate and electrocardiographic measurements were made at rest, at 1 minute intervals and for 6 minutes in recovery. Maximal predicted heart rate (220-age), %-predicted maximal heart rate, heart rate recovery (HRR, drop in heart rate from peak to 1 minute post exercise 27 ) and number of metabolic equivalents (METS) achieved were recorded. We calculated expected METs, based on age and gender. To calculate the expected METs for men, we used Veterans Affairs cohort formula (predicted METs=18-[0.15xage]) 28 . Similarly, for women, we used the St. James Take Heart Project formula (predicted METs=14.7-[0.13xage]) 29 .
These specific formulae for calculating expected METs have been previously demonstrated to best predict outcomes in respective genders 30 . We subsequently calculated the following ratio:
(METS achieved/age-gender expected METS)x100. Abnormal HRR was defined as <18 beat drop over 1 minute in recovery (as this test did not involve a cool-down period) 27 .
Immediately following exercise, peak-stress echocardiographic images were acquired, according to guidelines 31 , and the following parameters were assessed: regional wall motion abnormalities for evaluation of ischemia and peak-stress RVSP. We also evaluated for changes in LV cavity size (increase, decrease or no change), suggestive of presence or absence of contractile reserve 32 . Major (sustained ventricular or atrial arrhythmias associated with severe predicted maximal heart rate, heart rate recovery (HRR, drop in h r r eart rate from p p pea eak k k to to o 1 1 1 m m min in inu ute post exercise 27 ) and number of metabolic equivalents (METS) achieved were recorded. We ca alc lc cul ul ulat at ated ed ed e e exp xp pec cte te ted d METs, based on age and gen en nd de e er. To calculate te e the e e e ex xp xpected METs for men, w we u used Vetera ran n ns A Aff ff ffai a r rs rs c c coh oh oho or ort t fo fo for rm rmu ul ula a (pr re red dict ted ed d M M MET E ETs= s= =1 18 8-[ -[0. 0.15 15xa xa age e]) ]) 28 28 8 . . Si Sim mi mila la larl rl ly y y, f f for or wo wo ome me men, n, n, w we e e u us used ed d th he he S S St. J Jam ames es e T T Tak ak ake e e H He Hear ar art t t P P Proj oj ojec ec ect t f fo form rm mul ul ula a a (p (p pre re red d dict ct ted ed ed M M ME ET ETs s= s=14 14 1 .7 .7 7-[ -[ -[0 0.1 1 13x xa xage ge ge]) ) ) 29 .
These specif fic ic c f f for or rmu mu mula la ae e e fo o or r r ca ca c lc c cul ul ulat at tin in i g g g ex ex xpe pe pect ct cted ed e ME ME METs Ts s h h hav av ave e e be be been e e p p pre re revi vi viou ou ousl sl s y y de de demo mo mons ns n trated to symptoms, hemodynamic compromise, or need for cardioversion) and minor events (decrease in blood pressure, transient symptoms, or nonsustained arrhythmias) were recorded.
Follow up and outcomes
The date of first exercise echocardiography done at our institution was set as the beginning of observational period. Follow-up data was ascertained by chart review and recording the date at which cardiovascular events occured (whether locally or at our institution 
Statistical analysis
Continuous variables are expressed as mean±SD and/or median and compared using Student's Ttest (for normally distributed variables) or Mann-Whitney test (for non-normally distributed variables). Categorical data is expressed as percentage and compared using chi-square. To assess outcomes, Cox proportional hazards models were constructed. Initially, univariable analysis was performed testing all the relevant variables potentially associated with outcomes in this population. Subsequently, forward stepwise multivariable survival analysis was performed on all mpairment lasting <24 hours. All-cause mortality was obtained from medical re ec c cord rd r s s or or or f f fro ro rom m Social Security Death Index database (last query was in October 2012). A composite of all-cause mo mort rt rtal al alit it ity, y, M M MI I I, str tr ro ok oke, and progression to CHF wa wa was d defined as the e p p prima ma ary ry ry end point. In patients w who o o had unde erg rgon on one MV MV MV s sur urge ge gery ry, th th the e d da dat te an nd nd typ pe of MV MV M s s su ur rge gery ry a as s w we well ll a a as s an any y ad ad addi di dit ti t on on n l al al co on nc ncur ur urre rent nt p p pr ro roce ce edu u ure res s s (t (t tri ricu cusp sp spid id id v v val al alve ve e r rep ep epa a ai i ir, co co c ro r ron n nary ry ry a a art rt rte e ery y y by by bypa pa ass ss s g g gra a aft ftin in ng, g, g, e etc tc c.) .) ) wa a as category. Hazard ratios with 95% confidence intervals were calculated. The proportional hazards assumption was examined using inspection of Schoenfield residuals plotted against time.
Additionally, cumulative proportion of events as a function over time were obtained by KaplanMeier method and event curves were compared using log-rank test. Statistical analysis was performed using SPSS version 11.5 (SPSS Inc., Chicago, Illinois) and Stata version 10.0 (StataCorp, College Station, Texas). A p-value of <0.05 was considered significant.
Results
Baseline characteristics of the study population are shown in Table 1 . All patients had III+ myxomatous MR and underwent treadmill exercise echocardiography for further symptom evaluation, as they reported no or minimal symptoms (New York Heart Association class I-II).
Results of exercise and echocardiography are shown in Table 2 . Patients terminated the stress test due to generalized fatigue. At peak stress, 40 patients also had chest discomfort (none had dizziness or lightheadedness). There were no significant arrhythmias, syncope or deaths during exercise. 516 (58%) patients had a preserved LV ejection fraction ( 60%) and 810 (92%) had a normal indexed LV diastolic diameter (LV end-diastolic diameter<3.3 cm/m2). A majority (563 or 64%) patients had a dilated left atrium (area>20 cm2). anterior descending territory, 2 (5%) in left circumflex territory, 10 (23%) in the right coronary territory and 6 (14%) in a multivessel distribution.
Follow-up data
n the study, 576 (65%) patients underwent MV surgery (520 or 90% MV repair and 56 or 10%
MV replacement), with median time to surgery (from stress) being 3 months (interquartile range 
Outcomes and survival
At 6.4±4 years, 87 patients (10%) met the composite endpoint. The breakdown of endpoints was as follows: 44 (5%) deaths, 13 (1%) strokes, 13 (1%) transient ischemic attacks, 6 (0.7%) myocardial infarctions and 36 (4%) patients with progression to CHF. In patients who developed multiple endpoints, the time to the first event was utilized as an event-time cut-off. The proportion of events between surgical and non-surgical groups were similar (9% vs. 11%, p=0.2). In the surgical group of 576 patients, 5 patients had events prior to surgery. There were no deaths at 30-days post-operatively, while 1 patient had a stroke at day 29 post-operatively.
We further analyzed the data to evaluate whether worse outcomes occurred in patients
In the total group, 118 patients (13%) had new-onset AF during follow u up p p. Al Al Also so, , , th th ther er e e e were additional 36 (4%) patients who required pacemaker implantation and 10 (1%) patients with poor functional capacity due to other co-morbidites. As shown in Table 3 , within the subjects that achieved <85% age-gender predicted METs, the following subgroups had a higher proportion of events: older individuals, those with CAD, resting LV ejection fraction <55%, 
Discussion
This is a large study that evaluated mostly asymptomatic patients with III+ myxomatous MR undergoing stress echocardiography as part of symptom evaluation and risk stratification at a tertiary-care center. To the best of our knowledge, this is one of the largest studies to investigate the significance of clinical, echocardiographic and exercise variables in predicting outcomes of such patients, whose management is still controversial. We demonstrate that lower % agegender-predicted METs and abnormal HRR at 1-minute post-exercise, along with AF, increased RVSP and lower LV ejection fraction independently predicted worse outcomes. This effect was seen while the mean exercise capacity was higher than predicted (114 ± 27%).
In order to account for potential differences in exercise capacity, based on age and gender, we calculated a percentage of age-gender predicted METs in every individual, rather than utilizing absolute METs. We utilized previously validated formulae that have been demonstrated to have the most optimal performance to predict age-based METs, separately in men and women 30 . By further dividing the patients into 3 groups based on exercise capacity, we also demonstrate that patients who reach <85% of predicted METs were 3 times more likely to have events vs. those who achieved >100% of predicted METs. The proportion of events in the group achieving 85-100% of predicted METs was still twice as much as those achieving >100% RV RVS SP and low wer er r L L LV V ej e e e ec ecti ti tion on on f f fra ract ct ctio io on n in in ndep pen n nden n ntl ly y pr pr re ed edic ic cte e ed d w wo wors rse e ou o outc tcom om mes es. Th Th This is is e e eff f fe ec ect t wa w was e een en en w w whi hile le t t the he h m m mea a an n e ex exe er erci cise e e cap ap apac ac aci it ity y wa wa was s s h h high gh gher er r t th h han n n pr pr pred ed edic c cte te ted d d (1 (1 114 14 1 ± ± 2 2 27% 7% %). ).
In ord der er er t to o o ac ac acco co coun u u t t t fo fo for r r po po pote te t nt nt ntia a al l l di di diff ff ffer er eren en ence ce c s s s in in in e exe xe x rc rc rcis is i e e e ca ca capa pa aci ci city ty ty, , ba ba base se s d d d on on on a a age ge ge and to patients in >100% predicted METs group. However, subsequent proportion of events increased to a degree closer to patients with <85% predicted METs. This was in spite of the fact that all the study patients were deemed minimally symptomatic or asymptomatic and reliance purely on symptoms would not have identified patients at an increased risk. It is well known that in patients with significant MR, LV dysfunction can progress without symptoms 33 . Therefore, assessment of functional capacity on exercise testing can be an objective way of identifying patients at risk for future events.
Previous studies have demonstrated that worsening MR and appearance of symptoms is associated with worse outcomes 12, 13, 34 . It has also been suggested that early surgery was associated with improved outcomes 35 . However, it is apparent that not every asymptomatic patient with severe myxomatous MR needs to undergo immediate MV surgery. Some fear that even if complications of surgery are extremely low in this group, it will add some unwarranted deaths and morbidity. Previous reports have demonstrated the potential utility of exercise testing in predicting outcomes of asymptomatic patients with MR [21] [22] [23] . One report, that utilized cardiopulmonary exercise testing, demonstrated that exercise capacity was reduced in approximately 20-25% patients and was predictive of outcomes. However, the sample size was small, follow-up was only 2.2 years and only 57% patients had significant MR 21 . Other reports, have demonstrated that worsening of MR during exercise and exercise induced PHTN were associated with reduced symptom-free survival 22, 23 . However, these were much smaller studies where the endpoint was development of symptoms, rather than events. In our study, within a median time of 3 months, MV surgery was performed in 65% of our patients, notably with zero 30-day mortality, similar to a prior report 36 . In the current study, neither performance of surgery nor timing of surgery predicted outcomes. Similarly, type of MV surgery or concurrent associated with improved outcomes 35 . However, it is apparent that not every asy ymp mp mpto toma ma mati ti tic c c patient with severe myxomatous MR needs to undergo immediate MV surgery. Some fear that ev ven en en i i if f f co co omp mp m l lica a ati ti tio on ons of surgery are extremely lo lo ow w in this group, , i i it wi will ll ll a a add some unwarranted d de deat at ths h and mor orbi bi b d dity y. . P P Pre re evi viou ou ous s re re epo po port rts h have e e d d dem mon n nstr ra rat te ted d th h he e p p pot te tent nti i ial a a u uti tili li lity ty y o of f f ex ex xer erci c c s se se t te e est t ting n n p p pre re edi di d ct ctin in ng g g ou out tc co om ome es s o o of f as a ym ym ympt pt ptom om omat at tic ic p p pat at atie ent nt nts s wi wi w th th M M MR R R 2 21-2 2 23 R R . . O O One ne ne r re e epo or ort, t, t t tha ha hat t ut ut util il ili ize e ed cardiopulmon on nar ar ary y y ex ex exer er erci ci cise s t t tes es esti t ng ng ng, , de de demo mo mons ns nstr tr rat at ated ed ed t t tha ha h t t t ex exer er erci ci cise se se c c cap ap apac c cit it i y y y wa wa was s s re re r du du duce ce ced d d in in in d d
procedures did not affect the outcomes either. However, our study was not designed to investigate the role of surgery because there was no randomization, and the decisions for surgery had been made in real time, by evaluating physicians. To further tease out the impact of surgery, we evaluated the outcome of patients based on achieved METs (using 85% predicted as a cutoff) and whether or not they had MV surgery. The subgroup with the highest proportion of events consisted of patients who achieved <85% predicted METs and who did not undergo surgery. The In addition to reduced exercise capacity, abnormal HRR was another predictor of poor outcomes. Similar to prior reports, other known factors portending poorer outcomes included reduced LV ejection fraction, AF, and PHTN 13, 16, 19, 37, 38 . HRR after exercise is a result of vagal tone activation 39 and reduced HRR, reflecting blunted parasympathetic activity, has been linked to increased mortality 27, 40 . Indeed, in our study, patients with an abnormal HRR were almost 4
proportion of events approaching that of the other subgroups. The decision for su u urg rger e e y y y in in in % of the total number of patients with III+ MR seen at our institution in that time frame.
However, as mentioned in the supplemental file, the baseline demographics of the current population was similar to the total population, except for higher proportion of symptomatic patients, atrial fibrillation and flail MV leaflets.
Our patients also had similar characteristics to previously published data 8, 21, 35 . The mean age of our population was similar to the study by Rosenhek et al (58 vs. 55 years, respectively) with a similar proportion of men (67% vs. 63%, respectively) 8 . Also, the proportion of patients undergoing MV surgery in our population was similar (65% vs. 63%, respectively) to a previous report 3 . As with previous reports, our patients also had a 90% event-free rate during follow-up 8, 9 .
Different event rates have been reported in some other studies mainly due to differences in study criteria such as including a higher proportion of symptomatic patients 12, 14 , patients with LV dysfunction 37 , patients under medical management only 3, 13 , or only those with flail leaflets 3, 15, 18 .
While factors such as symptoms 3, 12 , severity of disease 13 and increased LV or LA dimensions 14, 15 lead to worse clinical outcomes, these predictors did not remain independently significant in the current study. However, prior studies did not necessarily have the same definition for However, as mentioned in the supplemental file, the baseline demographics of t the he e c c cur urre rent nt nt population was similar to the total population, except for higher proportion of symptomatic pa ati ti ien en ents ts ts, at at atri ri rial a a f fib ib br ri rill l ation and flail MV leaflets.
Our pa ati ti ie en ent t ts a als l l o o o ha ha had d d si si simi mila la l r r r c ch ha a aract t ter r ristic c cs s to p p pr re rev vi iou usl sly y y p pu publ bl blis i i h he hed d da da data ta 8, 8, 8, 21 21, 21, 35 35 35 . . Th Th The e me m mean ag age e e of of of o our ur p p po op opul ulat atio io i n n wa wa as s si imi mi mila la lar r r to to to t th he he s s stu tu tud dy dy b b by y y R Ro ose e enh nh hek ek ek e e et t t al al l (58 58 58 v vs s s. 55 55 y y yea ea ars rs, , re re resp sp pec ecti tive ve ely y) ) ) with a similar ar r p p pro ro r po po port rtio io ion n n of of of m m me en n n (6 (6 ( 7% 7% 7 v v vs. s. s. 6 6 63% 3% %, , re re resp sp spec ecti ti tive ve vely ly ly) ) ) 8 8 8 . . Al Al A so so so, , th th the e e pr pr prop op por or orti ti tion on on o of patients outcome 3, 8, 15, 16, 18 as the current study or had a smaller sample size 8 , included only patients with flail leaflets 14, 15, 18 or patients with varying cause 12, 19 or severity 3, 18 of MR. Also, stress echocardiography was not incorporated in the diagnostic algorithm.
Clinical Implications
There is increasing importance given to measuring exercise capacity in the general population and cardiovascular disease patients. Our study adds to the available data on utility of assessing exercise capacity in asymptomatic MR patients. Exercise testing yielded important prognostic information not obtained at rest. Therefore, a strategy that includes exercise testing may be considered in all asymptomatic patients with significant myxomatous MR. Indeed, the appropriate management of patients with asymptomatic yet severe MR is debatable and remains challenging. Our study with its results in regards to exercise capacity may offer a simple yet effective method of risk stratification in such patients. We showed that impaired exercise capacity (12 % patients achieved <85% of predicted METs) can develop in the absence of significant overt symptoms and is associated with adverse long-term outcomes. Therefore impairment in exercise capacity could be an objective surrogate of symptomatic deterioration and may therefore be used in clinical decision-making in asymptomatic patients. However, we would like to highlight the importance of calculating age and gender predicted METs, rather than utilizing absolute METs for the purpose of future risk prediction.
The current study has the following potential limitations. This is a large observational study in a referral center and therefore is not free of referral bias. However, as mentioned previously, the patients in the current study were similar to overall patients with III+ degenerative MR seen at our institution as well as those in previously published data 8, 21, 35 . We only included asymptomatic patients with III+ myxomatous MR that subsequently underwent appropriate management of patients with asymptomatic yet severe MR is debata ab b ble e an n nd d d re re rema ma m in ins challenging. Our study with its results in regards to exercise capacity may offer a simple yet ef ffe fe ect ct ctiv iv ive e me me m th th t od d d o o of f risk stratification in such pa a ati ti tien en nts. We showe ed d d that at t i i im m mpaired exercise f f ca apa a pacity (12 % % p p pat t tie ent nts ac ac ach hi hiev ev eved ed < < <8 85 85% % % o of p p pre e edict te ted d ME ME METs Ts) ) c ca can n d de eve vel l lo op op i in n th th the e ab ab bse se enc nce e of of of i ign gn gnif if fic ic ican ant t ov ov over ert t sy y ymp mp pto o oms ms a a and nd nd i i is s s as a asso so oci ci iat at ated ed ed w wi with th h a a adv dv ver erse se se l l lon n ng-g-g t te term rm rm o out utco co c m me mes. s. s T T The he heref f for re re mpairment i in n n ex ex e er er erci ci c se se e c c cap ap pac ac acit i i y y y co co c ul ul uld be be b a a an n n ob ob obje je ject ct ctiv iv ve e su su urr rr rrog og ogat at ate e e of of of s s sym ym ympt pt ptom om omat at tic ic ic d d det et eter er e ioration exercise echocardiography. Therefore, patients who have been more symptomatic at baseline did not have the test and are not included in our study. However, this has inherently helped us to focus on a population in whom uncertainties exist about optimal timing of surgical management.
We included patients over a broad time-frame and not all the quantitative MR and right ventricular functional measurements available today were performed in all patients. As a result we were not able to study the role of effective regurgitant orifice area, a factor that has been shown to determine mortality 13 , or tricuspid annular plane systolic excursion in the outcome of our patients. We do currently utilize quantitative Doppler measurement of MR severity, even though it can be argued that proximal isovelocity surface area measurements can be inaccurate in MR jets that are very eccentric. However, we reaffirmed MR severity in the current study population by repeat blinded evaluation of vena contracta, which was measurable from the digitally stored echo images. We did not perform cardiopulmonary stress testing in this population, as it would be very difficult to justify (from a cost perspective), especially when most of the patients were asymptomatic or minimally symptomatic. Also, a METs-based assessment is easy and can be applied broadly in clinical practice whereas % age-gender predicted METS is not well validated compared to using absolute METs. However, using absolute METs can potentially misclassify patients in terms of risk, based on age and gender.
Lastly, it should be kept in mind that exercise capacity is the output of overall function of cardiovascular, respiratory and musculoskeletal systems. Other possible etiologies of impaired exercise capacity could have played an important role in predicting outcomes in these patients.
Conclusion
In this large observational study of asymptomatic patients with III+ myxomatous MR undergoing exercise echocardiography, a sizable proportion did not achieve 100% of their age-MR jets that are very eccentric. However, we reaffirmed MR severity in the curre re ent nt t stu tu udy dy dy population by repeat blinded evaluation of vena contracta, which was measurable from the a di igi gi gita ta tall ll lly y st st stor or o e e ed e e ech ch cho o images. We did not perform m m ca ardiopulmonar ar ry y y stre re ess ss ss testing in this 9. 9. 9 6± 6± 6±3 3 3 9. 9. 9 4± 4± 4 3 3 3 9. 9. 9 4± 4± 4±3 3 3 0.2 Table 3 . Composite proportion of events in various clinically relevant subgroups separated on basis of whether they achieved > 85% age-gender predicted METS. 
